Amerx Health Care Corporation is a subsidiary of Procyon Corporation, stock symbol PCYN.

Amerx began operations in 1993 and manufactures proprietary wound and skin products, including the Amerigel® Skin and Wound Care product line. All manufacturing is done in the United States and complies with rigid GMP requirements.  Amerigel® products have been reviewed by the FDA (US Food & Drug Administration) and have individual NDC (National Drug Code) assigned to them. The product line currently consists of:

• AmeriGel® Wound Dressing
• AmeriGel® Hydrogel Saturated Gauze Dressing
• Amerigel® Saline Wound Wash
• Amerigel® Care Lotion
• Amerigel® Barrier Lotion

Amerigel® product formulations harness the natural healing power of the Oak tree. Oakin™, the primary ingredient, has been researched, tested and found to be beneficial to the skin and in the healing process of a variety of wounds. Amerx Health Care continues its research, testing, and development of innovative products. Amerigel® products are available over-the counter and do not require a prescription.

AmeriGel® Wound Dressing was the #1 rated (click here) product for the post-operative care of nail surgeries within the podiatry profession. (Podiatry Management Annual Survey, February 2004)

In 2003, Amerigel® products were reviewed by Health Canada and are now available in Canada. Amerx Health Care is currently seeking approval within the European market (EU), as well as other global markets.

Amerx Health Care is committed to providing high quality products to the medical community and to the consumer. Additional products are being researched and developed, as we diversify our presence to other medical professions and wound care practitioners.